Skip to main content

West Pharmaceutical Services Value Stock - Dividend - Research Selection

West pharmaceutical services

ISIN: US9553061055 , WKN: 864330

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


2 Safe-and-Steady Stocks with Solid Fundamentals and 1 We Question

2026-01-05
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Top 15 High-Growth Dividend Stocks For January 2026

2026-01-02
Top 15 high-growth dividend stocks beat SPY and VIG in December.

Best Dividend Aristocrats For January 2026

2025-12-31

West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day

2025-12-19
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day

West Pharmaceutical Services Stock: Is WST Underperforming the Healthcare Sector?

2025-12-17
Although West Pharmaceutical Services stock has underperformed the broader sector, analysts remain bullish about its prospects.

West Pharmaceutical Services (WST): Reassessing Valuation After a 20% Share Price Decline

2025-12-17
West Pharmaceutical Services (WST) has quietly slipped almost 20% over the past year, even as revenue and net income kept growing. That disconnect between share price and business performance is what makes the stock interesting now. See our latest analysis for West Pharmaceutical Services. Over the past year, West’s share price return has fallen sharply even as its three year total shareholder return remains positive. This suggests momentum has cooled lately as investors reassess growth...

West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors

2025-12-16
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors

1 S&P 500 Stock Worth Your Attention and 2 We Avoid

2025-12-16
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.

West Pharmaceutical Services Inc. stock underperforms Monday when compared to competitors despite daily gains

2025-12-15
West Pharmaceutical Services Inc. stock underperforms Monday when compared to competitors despite daily gains

West to Participate in Upcoming Investor Conference

2025-12-12
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 9:00 am PST in San Francisco, California.